RXRX logo

RXRX Operating Expenses

Annual Operating Expenses

$492.25 M
+$140.91 M+40.10%

December 31, 2024


Summary


Performance

RXRX Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRXRXexpensesmetrics:

Quarterly Operating Expenses

$175.49 M
+$63.13 M+56.19%

December 31, 2024


Summary


Performance

RXRX Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRXRXexpensesmetrics:

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

RXRX Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+40.1%+56.2%
3 y3 years+155.3%+56.2%
5 y5 years+667.3%+56.2%

RXRX Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+155.3%at high+228.1%
5 y5-yearat high+667.3%at high+863.3%
alltimeall timeat high+667.3%at high+863.3%

Recursion Pharmaceuticals Operating Expenses History

DateAnnualQuarterly
Dec 2024
$492.25 M(+40.1%)
$175.49 M(+56.2%)
Sep 2024
-
$112.36 M(+6.2%)
Jun 2024
-
$105.75 M(+7.2%)
Mar 2024
-
$98.67 M(-1.0%)
Dec 2023
$351.35 M(+48.2%)
$99.67 M(+0.9%)
Sep 2023
-
$98.78 M(+18.5%)
Jun 2023
-
$83.35 M(+19.8%)
Mar 2023
-
$69.55 M(+9.0%)
Dec 2022
$237.13 M
$63.82 M(+6.0%)
Sep 2022
-
$60.22 M(+1.0%)
Jun 2022
-
$59.62 M(+11.5%)
DateAnnualQuarterly
Mar 2022
-
$53.48 M(-20.7%)
Dec 2021
$192.78 M(+119.0%)
$67.46 M(+37.9%)
Sep 2021
-
$48.90 M(+12.6%)
Jun 2021
-
$43.43 M(+31.7%)
Mar 2021
-
$32.98 M(+17.2%)
Dec 2020
$88.03 M(+37.2%)
-
Dec 2020
-
$28.13 M(+20.6%)
Sep 2020
-
$23.34 M(+28.1%)
Jun 2020
-
$18.22 M(-0.7%)
Mar 2020
-
$18.34 M
Dec 2019
$64.15 M
-

FAQ

  • What is Recursion Pharmaceuticals annual total operating expenses?
  • What is the all time high annual operating expenses for Recursion Pharmaceuticals?
  • What is Recursion Pharmaceuticals annual operating expenses year-on-year change?
  • What is Recursion Pharmaceuticals quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Recursion Pharmaceuticals?
  • What is Recursion Pharmaceuticals quarterly operating expenses year-on-year change?

What is Recursion Pharmaceuticals annual total operating expenses?

The current annual operating expenses of RXRX is $492.25 M

What is the all time high annual operating expenses for Recursion Pharmaceuticals?

Recursion Pharmaceuticals all-time high annual total operating expenses is $492.25 M

What is Recursion Pharmaceuticals annual operating expenses year-on-year change?

Over the past year, RXRX annual total operating expenses has changed by +$140.91 M (+40.10%)

What is Recursion Pharmaceuticals quarterly total operating expenses?

The current quarterly operating expenses of RXRX is $175.49 M

What is the all time high quarterly operating expenses for Recursion Pharmaceuticals?

Recursion Pharmaceuticals all-time high quarterly total operating expenses is $175.49 M

What is Recursion Pharmaceuticals quarterly operating expenses year-on-year change?

Over the past year, RXRX quarterly total operating expenses has changed by +$63.13 M (+56.19%)